External Source

Trk Inhibition: Personal Experience With Larotrectinib

2019 4:36
Synopsis
Experts elucidate their personal experience in using the TRK inhibitor, larotrectinib, in patients with NTRK fusions.

You Might Also Like

The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers 0:52
The Impact Of Trk Inhibitor Loxo-101 (larotrectinib) On Pati...
2017
Larotrectinib, a TRK inhibitor for patients with solid tumors 1:15
Larotrectinib, A Trk Inhibitor For Patients With Solid Tumor...
2021
TRK Inhibition: Ongoing Challenges 4:07
Trk Inhibition: Ongoing Challenges
2018
Favorable Safety Profile in Novel TRK Inhibitor 3:30
Favorable Safety Profile In Novel Trk Inhibitor
2019
Updated Data With Larotrectinib in TRK Fusion-Positive Solid Tumors 1:20
Updated Data With Larotrectinib In Trk Fusion-positive Solid...
2019
Highlighting Promising TRK Inhibitors for the Treatment of Thyroid Cancer 1:12
Highlighting Promising Trk Inhibitors For The Treatment Of T...
2019
Dr. van Tilburg on Larotrectinib in TRK+ Pediatric Cancers 0:52
Dr. Van Tilburg On Larotrectinib In Trk+ Pediatric Cancers
2019
Moving Forward With TRK Inhibition 4:09
Moving Forward With Trk Inhibition
2018
Understanding Larotrectinib’s Safety Profile 2:40
Understanding Larotrectinib’s Safety Profile
2019
The future of TRK inhibitors in lung cancer treatment 1:16
The Future Of Trk Inhibitors In Lung Cancer Treatment
2024
Dr. Drilon on Activity of Larotrectinib in TRK Fusion–Positive NSCLC 1:35
Dr. Drilon On Activity Of Larotrectinib In Trk Fusion–posi...
2019
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.